Sounds reasonable, until you look at the Silicon Valley experience. Silicon Valley grew like a weed precisely because employees could…
Morning Headlines 4/9/19
Apple’s Health Opportunity Could be Triple Smartphone Market
Morgan Stanley analysts determine that Apple’s piece of the consumer-centered health pie could eventually be between $15 billion and $313 billion.
With help from Nuance and GE Healthcare, the American College of Radiology adds Nvidia’s Clara AI Toolkit to free software it will offer radiologists to help them develop and use AI for diagnostic radiology.
Deep Lens raises $14 million to improve clinical trial recruitment with AI
Digital pathology imaging and diagnosis startup Deep Lens secures $14 million in a Series A round led by Northpond Ventures.
Info for wrong patients possibly sent to thousands of West Virginia veterans
The Veterans Health Administration notifies 4,882 patients of a Xerox software and printing problem that resulted in PHI, including lab results, being mailed to the wrong patients.
Guess we’re already back to over-hyped valuations in the healthcare industry. Between $15 and $313 billion??? What is their specific analysis? Where is the value? Apple’s competitive advantage?
“Morgan Stanley looked at how Apple platforms could disrupt various processes in the health-care industry and used the integrated iPhone/iPad, iOS, App Store ecosystem as a guide for how much cost savings could ultimately accrue to the company.”
I really don’t understand why half of Wall St. is just putting blind faith in Apple. This basically amounts to “healthcare is a big industry, Apple is a company that could take advantage of this industry”. Do any of these analysts realize that Apple devices and the App store are already used in healthcare? And that it’s not making an impact on patient outcomes or the company bottom line?
Loved the Chicago reference there!